Finerenone and Blood Pressure in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

Дата публикации: 08-07-2026 00:00:00

This randomized clinical trial analyzes whether finerenone lowers blood pressure and whether its cardiovascular benefits in patients with mildly reduced or preserved ejection fraction heart failure depend on baseline blood pressure or blood-pressure reduction.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Left Ventricular Dimension and Mortality in Patients With Heart Failure	0	3.96	05-08-2026
2	Doctors thought this kidney drug helped some patients. It may help millions more.	0	6.28	08-06-2026
3	A New Understanding of HFpEF in Severe Obesity	0	7.54	23-06-2026
4	Spectrum of Aldosteronism and Cardiovascular Outcomes	0	6.27	01-04-2026
5	STAT+: Heart failure drug from Tenax Therapeutics fails in pivotal study	0	5.33	10-08-2026
6	Finerenone helps slow kidney disease in patients without diabetes	5	8	07-07-2026
7	Review of Diagnosis and Management of Resistant Hypertension	0	5.48	18-08-2026
8	Cognitive Outcomes After Catheter Ablation for Atrial Fibrillation	0	8.06	31-07-2026
9	Seven-Year Valve Durability With TAVR	0	11.52	01-08-2026
10	Few patients with CKD meet systolic blood pressure target	0	9.25	11-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5.21. Источник: jamanetwork.com.